Exploring Big Data in Hematological Malignancies: Challenges and Opportunities

被引:1
|
作者
Westin, Gustavo F. [1 ]
Dias, Ajoy L. [1 ]
Go, Ronald S. [1 ]
机构
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
关键词
Acute myeloid leukemia; Hodgkin lymphoma; Diffuse large B cell lymphoma; Multiple myeloma; Amyloidosis; Hematopoietic stem cell transplantation; CHRONIC LYMPHOCYTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; CHEMOTHERAPY PLUS RITUXIMAB; STAGE HODGKINS LYMPHOMA; ACUTE MYELOID-LEUKEMIA; HIGH-DOSE MELPHALAN; HEALTH-CARE-SYSTEM; MULTIPLE-MYELOMA; ELDERLY-PATIENTS; UNDETERMINED SIGNIFICANCE;
D O I
10.1007/s11899-016-0331-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Secondary analysis of large datasets has become a useful alternative to address research questions outside the reach of clinical trials. It is increasingly utilized in hematology and oncology. In this review, we provided an overview of some examples of commonly used large datasets in the USA and described common research themes that can be pursued using such a methodology. We selected a sample of 14 articles on adult hematologic malignancies published in 2015 and highlighted their contributions as well as limitations.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 50 条
  • [41] The functions and clinical significance of circRNAs in hematological malignancies
    Zhou, Xiangxiang
    Zhan, Linquan
    Huang, Kai
    Wang, Xin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [42] Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
    Sud, Amit
    Chattopadhyay, Subhayan
    Thomsen, Hauke
    Sundquist, Kristina
    Sundquist, Jan
    Houlston, Richard S.
    Hemminki, Kari
    BLOOD, 2019, 132 (12) : 960 - 969
  • [43] SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
    Alvaro Andrades
    Paola Peinado
    Juan Carlos Alvarez-Perez
    Juan Sanjuan-Hidalgo
    Daniel J. García
    Alberto M. Arenas
    Ana M. Matia-González
    Pedro P. Medina
    Molecular Cancer, 22
  • [44] Challenges and optimal strategies of CAR T therapy for hematological malignancies
    Zhang, Yajing
    Xu, Yang
    Dang, Xiuyong
    Zhu, Zeyu
    Qian, Wenbin
    Liang, Aibin
    Han, Weidong
    CHINESE MEDICAL JOURNAL, 2023, 136 (03) : 269 - 279
  • [45] Challenges and optimal strategies of CAR T therapy for hematological malignancies
    Zhang Yajing
    Xu Yang
    Dang Xiuyong
    Zhu Zeyu
    Qian Wenbin
    Liang Aibin
    Han Weidong
    中华医学杂志英文版, 2023, 136 (03)
  • [46] SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
    Andrades, Alvaro
    Peinado, Paola
    Alvarez-Perez, Juan Carlos
    Sanjuan-Hidalgo, Juan
    Garcia, Daniel J. J.
    Arenas, Alberto M. M.
    Matia-Gonzalez, Ana M. M.
    Medina, Pedro P. P.
    MOLECULAR CANCER, 2023, 22 (01)
  • [47] MicroRNAs in Autoimmunity and Hematological Malignancies
    Di Marco, Mirco
    Ramassone, Alice
    Pagotto, Sara
    Anastasiadou, Eleni
    Veronese, Angelo
    Visone, Rosa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [48] Expression of non-coding RNAs in hematological malignancies
    Ghafouri-Fard, Soudeh
    Esmaeili, Mohammadhosein
    Taheri, Mohammad
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 875
  • [49] Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
    Little, Jessica S.
    Weiss, Zoe F.
    Hammond, Sarah P.
    JOURNAL OF FUNGI, 2021, 7 (12)
  • [50] Redirecting T cells to hematological malignancies with bispecific antibodies
    Velasquez, Mireya Paulina
    Bonifant, Challice L.
    Gottschalk, Stephen
    BLOOD, 2018, 131 (01) : 30 - 38